ahlam1399
09-09-2015, 01:52 AM
Tetraphase?s bowel drug fails late-stage study, shares slump
(Reuters) - Tetraphase Pharmaceuticals Inc said its experimental bowel drug failed to meet the main goal in a late-stage study, sending its shares down 75 percent in extended trading.
http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2.img (http://da.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/ach.img (http://adchoice.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/ach.htm)http://pi.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49ad6c6f/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=zBFMVROk0KY:ChwXquilYxM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=zBFMVROk0KY:ChwXquilYxM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=zBFMVROk0KY:ChwXquilYxM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=zBFMVROk0KY:ChwXquilYxM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=zBFMVROk0KY:ChwXquilYxM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/zBFMVROk0KY
(Reuters) - Tetraphase Pharmaceuticals Inc said its experimental bowel drug failed to meet the main goal in a late-stage study, sending its shares down 75 percent in extended trading.
http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/1/rc.img (http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/1/rc.htm)
http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/2/rc.img (http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/2/rc.htm)
http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/3/rc.img (http://rc.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/rc/3/rc.htm)
http://da.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2.img (http://da.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2.htm)
http://adchoice.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/ach.img (http://adchoice.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/ach.htm)http://pi.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2t.imghttp://pi2.feedsportal.com/r/238385426075/u/49/f/654207/c/35217/s/49ad6c6f/sc/14/a2t2.imghttp://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654207/s/49ad6c6f/sc/14/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=zBFMVROk0KY:ChwXquilYxM:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=zBFMVROk0KY:ChwXquilYxM:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=zBFMVROk0KY:ChwXquilYxM:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=zBFMVROk0KY:ChwXquilYxM:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=zBFMVROk0KY:ChwXquilYxM:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/zBFMVROk0KY